Last reviewed · How we verify

NCT05253274: Virtual

The Effect of Virtual Reality Glasses Applied During Emergency Surgical Intervention

Completed NA Last updated 7 April 2022
What this trial tests

NA trial testing Virtual Reality Glasses in Anxiety in 138 participants. Completed in 24 March 2022.

Timeline
20 February 2022
Primary endpoint
20 February 2022
24 March 2022

Quick facts

Lead sponsorMersin University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposesupportive care
Enrollment138
Start date20 February 2022
Primary completion20 February 2022
Estimated completion24 March 2022
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Mersin University

Who can join

Adults 18 to 65, any sex, with Anxiety. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This randomized controlled trial evaluates the effect of virtual reality glasses applied during emergency surgical intervention with local anesthesia on patients anxiety. This study hypothesizes that virtual reality glasses reduces anxiety.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Virtual Reality Glasses

Trials testing the same drug.

Other recruiting trials for Anxiety

Currently open trials in the same condition.

Other Mersin University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05253274.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing